MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹314 Cr | ₹266 Cr | ₹185 Cr | ₹236 Cr | ₹117 Cr |
What is the latest Consolidated Net Profit of MARKSANS PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹314 Cr |
Mar2023 | ₹266 Cr |
Mar2022 | ₹185 Cr |
Mar2021 | ₹236 Cr |
Mar2020 | ₹117 Cr |
How is Consolidated Net Profit of MARKSANS PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹314 Cr | 17.80 | |
Mar2023 | ₹266 Cr | 44.29 | |
Mar2022 | ₹185 Cr | -21.77 | |
Mar2021 | ₹236 Cr | 101.62 | |
Mar2020 | ₹117 Cr | - |
Compare Consolidated Net Profit of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,538.5 Cr | -1.2% | -2.3% | 37.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -1.2% |
-2.3% |
37.5% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses